RDHL 总资产历史(2016–2024)
REDHILL BIOPHARMA LTD. (RDHL) 各财年年末总资产(来自 SEC 财报)。
$18.0MFY2024 · FY2016 以来:$74.2M → $18.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2024 | $18.0M | -21.7% |
| FY2023 | $23.0M | -85.5% |
| FY2022 | $158.9M | -12.3% |
| FY2021 | $181.2M | +0.5% |
| FY2020 | $180.2M | +143.2% |
| FY2019 | $74.1M | +18.7% |
| FY2018 | $62.4M | +8.8% |
| FY2017 | $57.3M | -22.7% |
| FY2016 | $74.2M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议